![Peter D. Flynn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter D. Flynn
Plus aucun poste en cours
Profil
Peter D.
Flynn worked as a Director of Biochemistry Research at Humanigen, Inc. and as a Vice President of Engineering at Ren Pharmaceuticals, Inc. He was also a Senior Vice President of Early Program Development at Fate Therapeutics, Inc. from 2013 to 2015.
From 2015 to 2018, he served as the SVP and Head of Development, Regulatory Affairs & Safety at Orexigen Therapeutics, Inc. Prior to his industry career, he worked as a researcher at UCSF Medical Center.
Flynn received his undergraduate degree from University College London.
Anciens postes connus de Peter D. Flynn
| Sociétés | Poste | Fin |
|---|---|---|
| OREXIGEN THERAPEUTICS, INC. | Conseiller Juridique Général | 27/07/2018 |
| FATE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2015 |
| HUMANIGEN, INC. | Corporate Officer/Principal | - |
UCSF Medical Center
 UCSF Medical Center Hospital/Nursing ManagementHealth Services Owns and operates hospitals | Directeur Technique/Scientifique/R&D | - |
Ren Pharmaceuticals, Inc.
 Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceuticals products | Corporate Officer/Principal | - |
Formation de Peter D. Flynn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
32
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the treatment of obesity | Health Technology |
Ren Pharmaceuticals, Inc.
Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceuticals products | Health Technology |
UCSF Medical Center
UCSF Medical Center Hospital/Nursing ManagementHealth Services Owns and operates hospitals | Health Services |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
